GlassScriptPhysician profile
George Stoupakis
NPI 1235103243
$6,404.89
in general payments reported to CMS, 2019-2025
36 companies · $862 in 2025
The $862 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $752 · 2020: $391 · 2021: $1,068 · 2022: $1,188 · 2023: $997 · 2024: $1,147 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,890 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,889.84 |
| Education | $116.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $873.38 | 2019-2025 | |
| Abiomed | $671.30 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $590.11 | 2019-2025 | Farxiga, Andexxa, Wainua |
| Cvrx, INC. | $496.95 | 2022-2025 | Barostim Neo System |
| Penumbra, INC. | $359.29 | 2022 | |
| Amgen INC. | $338.16 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $272.65 | 2021-2025 | Verquvo |
| Shockwave Medical, INC | $262.68 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $254.57 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $245.62 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $236.47 | 2019-2024 | Watchman Flx |
| Medtronic, INC. | $164.00 | 2025 | Selectsecure |
| Arbor Pharmaceuticals, INC. | $162.06 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $148.95 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $135.07 | 2021-2025 | Aveir, Perclose Prostyle, Thoratec Heartmate 3 Lvas Implant Kit |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Stoupakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.